Insulet (PODD) EBT (2010 - 2026)

Insulet (PODD) has reported EBT for 17 consecutive years, with $118.7 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, EBT rose 317.96% year-over-year to $118.7 million; the trailing twelve-month figure through Jun 2026 stood at $494.7 million (up 82.61% YoY), and the FY2025 full-year result was $339.5 million, up 13.09% from the prior year.
• EBT advanced to $118.7 million in Q2 2026 per PODD's latest filing, from $113.0 million in the prior quarter.
• Across five years, EBT topped out at $140.2 million in Q4 2025 and bottomed at -$36.1 million in Q2 2022.
• Historically, EBT has averaged $60.9 million across 5 years, with a median of $52.4 million in 2023.
• The widest YoY moves for EBT: up 9666.67% in 2022, down 137.5% in 2022.
• Over 5 years, EBT stood at $22.3 million in 2022, then jumped by 383.86% to $107.9 million in 2023, then rose by 3.24% to $111.4 million in 2024, then rose by 25.85% to $140.2 million in 2025, then declined by 15.34% to $118.7 million in 2026.
• According to Business Quant data, EBT over the past three periods registered $118.7 million, $113.0 million, and $140.2 million for Q2 2026, Q1 2026, and Q4 2025 respectively.